"Investigación clínica, ensayos clínicos, Investigación médica, consulta médica, medicina interna"

During the past decade, Rodrigo Botero S.A.S. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 11 clinical trials were completed, i.e. on average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rodrigo Botero S.A.S." #1 sponsor was "Pfizer" with 5 trials, followed by "Allergan" with 4 trials sponsored, "Bayer" with 2 trials sponsored, "Corvus Pharmaceuticals, Inc." with 1 trials sponsored and "EirGenix, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rodrigo Botero S.A.S." #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rodrigo Botero S.A.S." are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Cardiovascular Disease" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Rodrigo Botero S.A.S." in a lesser frequency.

Most popular intervention types in "Rodrigo Botero S.A.S." are "Drug" (12 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Relamorelin" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rodrigo Botero S.A.S." are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Rodrigo Botero S.A.S.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Rodrigo Botero S.A.S., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Rodrigo Botero S.A.S., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".